<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	
	xmlns:georss="http://www.georss.org/georss"
	xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#"
	>

<channel>
	<title>Multi-national &#8211; Organization for Competitive Markets</title>
	<atom:link href="https://competitivemarkets.com/tag/multi-national/feed/" rel="self" type="application/rss+xml" />
	<link>https://competitivemarkets.com</link>
	<description></description>
	<lastBuildDate>Fri, 03 Jan 2014 15:20:28 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>

<image>
	<url>https://i0.wp.com/competitivemarkets.com/wp-content/uploads/2017/06/cropped-logo-square.jpg?fit=32%2C32&#038;ssl=1</url>
	<title>Multi-national &#8211; Organization for Competitive Markets</title>
	<link>https://competitivemarkets.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">41386461</site>	<item>
		<title>UN-COOL</title>
		<link>https://competitivemarkets.com/un-cool/</link>
		
		<dc:creator><![CDATA[Richard Oswald]]></dc:creator>
		<pubDate>Fri, 03 Jan 2014 07:04:33 +0000</pubDate>
				<category><![CDATA[Corporate Power]]></category>
		<category><![CDATA[General Advocacy]]></category>
		<category><![CDATA[COOL]]></category>
		<category><![CDATA[country of origin labeling]]></category>
		<category><![CDATA[lobbyists]]></category>
		<category><![CDATA[Multi-national]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<guid isPermaLink="false">http://www.competitivemarkets.com/?p=2041</guid>

					<description><![CDATA[<p><img width="295" height="180" src="https://competitivemarkets.com/wp-content/uploads/2014/01/COOL-Labeling-295x180.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" fetchpriority="high" /></p>By Richard Oswald Not too long ago, the worlds pharmaceutical companies lobbied Congress to drop strict safety guidelines saying those placed an undue burden on America. It was unconstitutional they said, by driving up the cost of medicine. US consumers shouldn&#8217;t care where medicine came from. It was none of their business actually, so long as they received adequate assurances of safety and effectiveness. It was the most efficient way, they said, to keep prices low. Pill imports <a href="https://competitivemarkets.com/un-cool/" class="read-more">Read More ...</a>]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2041</post-id>	</item>
	</channel>
</rss>
